TEVA PHARMACEUTICAL INDUSTRIES LIMITED Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2011-12-31 | $12.00M 20-F · filed 2014-02-10 | |
| 2010-12-31 | $92.00M 20-F · filed 2013-02-12 | |
| 2009-12-31 | $965.00M 20-F · filed 2012-02-17 | |
| 2008-12-31 | $31.00M 20-F · filed 2011-02-15 |